OLERIVE
LIVE

Serial Number

79203564

Owner

NOVARTIS AG

Filing Date

Sep 3, 2016

Add to watchlist:

No watchlists yet
View on USPTO

OLERIVE Trademark

Serial Number: 79203564 • Registration: 5243583

OLERIVE is a trademark filed by NOVARTIS AG on September 3, 2016. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

NOVARTIS AG (7,166 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

September 3, 2016

Registration Date

July 18, 2017

Published for Opposition

May 2, 2017

Cancellation Date

May 20, 2019

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculoskeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Filing History

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Dec 23, 2019 DENC
DEATH OF INTERNATIONAL REGISTRATION
Dec 23, 2019 DETH
NOTIFICATION PROCESSED BY IB
Nov 3, 2017 GPNX
FINAL DISPOSITION NOTICE SENT TO IB
Aug 18, 2017 FICS
FINAL DISPOSITION PROCESSED
Aug 18, 2017 FIMP
GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Aug 17, 2017 GPAR
REGISTERED-PRINCIPAL REGISTER
Jul 18, 2017 R.PR
PUBLISHED FOR OPPOSITION
May 2, 2017 PUBO
NOTICE OF PUBLICATION
Apr 12, 2017 NPUB
APPLICATION FILING RECEIPT MAILED
Mar 24, 2017 MAFR
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 21, 2017 CNSA
ASSIGNED TO EXAMINER
Mar 20, 2017 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 20, 2017 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Mar 17, 2017 LIMI
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Mar 16, 2017 SDRC